Skip to main content
S

Synaptica

Synaptica provides AI‑driven mobile applications that enable patients with rare diseases, their families, and caregivers to log symptoms and medication data via voice commands or OCR, converting this information into structured digital records. The platform analyzes the collected data to deliver real‑time, condition‑specific insights for users, clinicians, and pharmaceutical partners, supporting better care coordination and real‑world evidence generation.

Founded 20247100+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patients, families, and caregivers of rare disease patients often lack efficient tools to consistently track symptoms, manage complex medication regimens, and obtain actionable health insights, leading to fragmented care and suboptimal outcomes.

Solution

Synaptica offers AI‑driven mobile applications that simplify rare disease management by enabling voice‑based symptom logging and OCR conversion of handwritten journals into structured digital data. The platform analyzes this patient‑reported information to generate real‑time, actionable insights for caregivers, clinicians, and researchers. By integrating these insights with pharmaceutical partners, Synaptica supports medication adherence, patient engagement, and the collection of real‑world evidence to inform care decisions. The apps are tailored to specific conditions such as epilepsy, Lennox‑Gastaut Syndrome, and Dravet Syndrome, providing condition‑specific guidance and alerts.

Target Audience

Primary users are patients with rare diseases, their families, and caregivers, as well as healthcare providers and pharmaceutical companies seeking real‑world data and improved patient engagement.

Features

  • Voice‑activated data entry that transcribes spoken inputs into structured health records
  • OCR technology for digitizing existing handwritten or printed patient logs
  • AI analytics that transform raw symptom and medication data into actionable care insights
  • Condition‑specific modules for rare diseases like epilepsy, Lennox‑Gastaut Syndrome, and Dravet Syndrome
  • Secure cloud storage and data sharing capabilities for clinicians and pharmaceutical partners
  • User‑friendly mobile interface designed for patients, families, and caregivers
This profile is AI-generated and may contain inaccuracies.